-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|July 1, 2003

The American Journal of Managed Care

July 2003
Volume 9
Issue 7

An Exploratory Cost Analysis of Performing Hospital-Based Concurrent Utilization Review

Author(s)Mary Ellen Murray, PhD, RN, Jeffrey B. Henriques, PhD

Download PDF: An Exploratory Cost Analysis of Performing Hospital-Based Concurrent Utilization Review

Articles in this issue

about 23 years ago

Article

Managed Care in the Genomics Era: Assessing the Cost Effectiveness of Genetic Tests

about 23 years ago

Article

Variation in Racial and Ethnic Differences in Consumer Assessments of Health Care

about 23 years ago

Article

Allocating Funds for Cardiovascular Disease Prevention in Light of the NCEP ATP III Guidelines

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC Letter to the Editor

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

AJMC original research policy

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

AJMC commentary

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

AJMC commentary

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

AJMC original research policy

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer